FRANKFURT May 19 German drugs and chemicals maker Merck KGaA expects adjusted core earnings to increase by up to 18.5 percent this year, helped by additional profit from a takeover of lab supplies maker Sigma-Aldrich.
Merck forecast full-year earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-off items, to rise to between 4.1 billion euros ($4.6 billion) and 4.3 billion euros, up from 3.63 billion in 2015.
07:49 Murdoch's Twenty-First Century Fox Bids $14 Billion For UK's Sky11
02:11 Murdoch Pounces on Sky as Lower Pound Makes Takeover Cheaper8
22:36 Trump surveys rallygoers on whether Time magazine’s ‘Person of the Year’ is too PC11
19:34 CEO shift at Coca-Cola could usher in more dealmaking to refresh soda giant's growth13